Modag Gmbh
Clinical trials sponsored by Modag Gmbh, explained in plain language.
-
New PET tracer aims to spot Parkinson's in the brain
Diagnosis Recruiting nowThis early-phase study tests a new radioactive tracer called [¹⁸F]MODAG-009, which is designed to stick to abnormal clumps of a protein called alpha-synuclein in the brain. These clumps are linked to Parkinson's disease and multiple system atrophy (MSA). About 13 people—including…
Phase: EARLY_PHASE1 • Sponsor: MODAG GmbH • Aim: Diagnosis
Last updated Jun 23, 2026 11:59 UTC
-
New imaging agent tested in healthy people
Knowledge-focused Recruiting nowThis study is testing a new radioactive tracer called [18F]MODAG-009 in 6 healthy adults. The goal is to see how the tracer moves through the body and how much radiation exposure it causes. Participants get one injection and then a full-body PET scan. This is an early-phase study…
Phase: EARLY_PHASE1 • Sponsor: MODAG GmbH • Aim: Knowledge-focused
Last updated Jun 10, 2026 13:27 UTC